The report is titled ‘Rabies Diagnostics Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the rabies diagnostics market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The rabies diagnostics market is expected to grow at a significant rate in the near future.
The global rabies diagnostics market in 2020 is estimated for more than US$ 1.7 Bn and expected to reach a value of US$ 2.3 Bn by 2028 with a significant CAGR of 4.2%.
Request a Sample Copy of this Report @: https://reportsandinsights.com/sample-request/1306
Rabies Diagnostics Market Dynamics
Increasing awareness about animal-related diseases is the prime market driving factor. In addition, the factors like the escalating count of awareness programs organized by the government to combat the ill effects of rabies, the necessity of immunization for both humans and animals, healthy surveillance strategies and the development of suitable rabies diagnostics kits also positively impacts the market growth during the forecast years.
Additionally, the initiatives like mass dog vaccinations, adoption of post-exposure prophylaxis (PEP), and the government’s involvement to create appropriate laws linked with the diagnosis of rabies virus also aids the growth of the rabies diagnostics market.
As per the Prevention and Control of Rabies in India’s (APCRI) 2018 journal, India alone counts for approximately 36% of the total deaths due to rabies, followed by China. Moreover, this country is also recorded to have a maximum count of street dogs, which further propels the demand for rabies diagnostics.
However, the lack of awareness about the technological advancements along with the high cost linked with rabies diagnosis results in restricting the market growth.
On the other hand, the increasing investments for supporting the on-going research activities for the invention of rabies diagnosis kits are expected to create growth opportunities for the market during the upcoming years.
Wish to Know More About the Study? Click here to get a Report Description: https://reportsandinsights.com/pressrelease/rabies-diagnostics-market
Rabies Diagnostics Market Segmentation
Global rabies diagnostics market is segmented on the basis of diagnostic method, technology, and region.
By Diagnostic Method:
-  Fluorescent Antibody Test (FAT)
-  Immunohistochemical Test
-  Amplification Methods
-  Histologic Examination
-  Serology Tests
By Technology:
-  ELISA/Immunohistochemistry
-  Chromatography techniques
-  PCR
-  Others
By Region:
-  North America
-  Europe
-  Asia Pacific
-  Latin America
-  Middle East
-  Africa
Rabies Diagnostics Market Pipeline Drugs Overview
The global rabies diagnostics market is also influenced by the existing drugs in the pipeline, which accounts for the presence of rAdC68 rabies vaccine that has been tested in non-human primates without pre-existing immunity adenovirus, as per the Wistar Institute. The rAdC68 rabies prophylactic vaccine, developed by the institute is in pipeline and is seeking collaboration to study the final stage development of this vaccine by conducting the clinical trials.
Rabies Diagnostics Market Competitive Landscape
Key players operating in the global rabies diagnostics market include Abbexa Ltd., Aviva Systems Biology Corporation, BioNote, Inc., Bio-Rad Laboratories, Inc., Creative Diagnostics, Demeditec Diagnostics GmbH, Express Biotech International Inc., Merck KGaA, MyBioSource.com, Norgen Biotek Corp., and The Wistar Institute.
To view Top Players, Segmentation and other Statistics of Rabies Diagnostics Industry, Get Sample Report @: https://reportsandinsights.com/sample-request/1306
About Reports and Insights:
Reports and Insights is one of the leading market research companies which